Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

MisterNiceKitty

(422 posts)
Wed Aug 18, 2021, 09:09 PM Aug 2021

New Lab Study Claims Common Drug Can Reduce COVID-19 Infection By Up To 70%

https://texasbreaking.com/2021/08/new-lab-study-claims-common-drug-can-reduce-covid-19-infection-by-up-to-70/

"Covid-19 infections could be reduced by as much as 70% by the use of a drug that has been approved by most countries in the world, including the U.S. Food and Drug Administration (FDA) and the UK’s National Institute for Health and Care Excellence (NICE), according to a new study.

The study conducted in the laboratory by an international collaboration of researchers said that results showed a 70% reduced chance of infection by SARS-CoV-2 could be possible by a licensed drug generally used for the treatment of ailments like high levels of cholesterol and lipids in human blood.

The research team led by the University of Birmingham and Keele University in the U.K. and the San Raffaele Scientific Institute in Italy said that the use of fenofibrate and its active form, fenofibric acid, has the ability to significantly reduce SARS-COV-2 infection in human cells."
5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
New Lab Study Claims Common Drug Can Reduce COVID-19 Infection By Up To 70% (Original Post) MisterNiceKitty Aug 2021 OP
If true this would be very good news Lettuce Be Aug 2021 #1
fenofibrate and fenofibric acid, generics cadoman Aug 2021 #2
another one in Israel to watch cadoman Aug 2021 #3
Thanks for the info MisterNiceKitty Aug 2021 #5
Oh, thank heavens it wasn't Hydroxychloroquine TlalocW Aug 2021 #4

cadoman

(792 posts)
2. fenofibrate and fenofibric acid, generics
Thu Aug 19, 2021, 12:30 AM
Aug 2021

IANAS. It appears the study referenced in the article was done on models.

https://www.frontiersin.org/articles/10.3389/fphar.2021.660490/full

Here's another study in progress that is a RCT of 700 participants:

https://www.clinicaltrials.gov/ct2/show/NCT04517396

"...fenofibrate...markedly inhibited SARS-CoV-2 viral replication. Fenofibrate also has immunomodulatory effects that may be beneficial in the setting of COVID-19."

That study ends October 31, 2021.

Latest Discussions»General Discussion»New Lab Study Claims Comm...